OncoTherapy Science, Inc. (TYO:4564)
Japan · Delayed Price · Currency is JPY 22.00
-1.00 (-4.35%)
Sep 16, 2026, 3:30 PM JST
OncoTherapy Science Market Cap
OncoTherapy Science has a market cap or net worth of 9.39 billion as of September 15, 2026. Its market cap has increased by 18.54% in one year.
Market Cap
9.39B
Enterprise Value
7.06B
Revenue
777.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.00
ChartMarket Cap Chart
Since June 29, 2007, OncoTherapy Science's market cap has decreased from 13.84B to 9.39B, a decrease of -32.17%. That is a compound annual growth rate of -2.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 9.39B | 36.62% |
| Dec 30, 2025 | 6.87B | 1.20% |
| Dec 30, 2024 | 6.79B | 35.66% |
| Dec 29, 2023 | 5.01B | -50.03% |
| Dec 30, 2022 | 10.02B | -27.78% |
| Dec 30, 2021 | 13.87B | -31.60% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| StemRIM | 11.28B |
| Kubota Pharmaceutical Holdings | 10.86B |
| Immuno-Biological Laboratories | 10.82B |
| K Pharma,Inc. | 9.45B |
| Carna Biosciences | 9.14B |
| CellSeed | 8.91B |
| Nano Holdings | 8.76B |
| Kidswell Bio | 8.35B |